Delivery Order SPE2DB20D6035-SPE2DB24FD1QE
Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $3.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 27 mg tablets of the pharmaceutical product Methylphenidate ER. The $1,566.00 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, as well as an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,398.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of Methylphenidate ER 36 mg. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,731,300 units of Methylphenidate ER 18 mg tablets. The contract, valued at $1,894.65, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to the agency. This award is...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,406.04 firm fixed price delivery order contract to supply 100 units of Methylphenidate ER 36 mg tablets. This order falls under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,840,466 units of Methylphenidate ER 27 mg tablets. The contract has a completion date of March 5, 2024 and a potential value of $4,013.20. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,873,177 units of Methylphenidate ER 54 mg tablets in 100-count bottles. The contract has a total potential value of $1,371.80 and a completion date of March 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,501,499 units of Methylphenidate ER 54 mg tablets in lots of 100. The contract has a completion date of January 29, 2024 and a potential value of $10,198.63. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to supply 4,563,666,767 tablets of Methylphenidate ER 27 mg. The $3,884.34 contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp that has a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,441.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,449,365 tablets of Methylphenidate ER 54 mg. The delivery order has a completion date of January 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used for this award. The delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,605,231 tablets of 36 mg Methylphenidate ER (extended-release). The contract has a completion date of February 9, 2024 and a potential value of $1,547.85. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a maximum potential...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD1QEDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,413.91 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of 27 mg Methylphenidate ER. The contract, which has a completion date of January 26, 2024, is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Generated 4/25/24, 7:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/25/24 |